Control of nuclear size by osmotic forces in Schizosaccharomyces pombe

  1. Joël Lemière
  2. Paula Real-Calderon
  3. Liam J Holt
  4. Thomas G Fai  Is a corresponding author
  5. Fred Chang  Is a corresponding author
  1. Department of Cell and Tissue Biology, University of California, San Francisco, United States
  2. Centro Andaluz de Biología del Desarrollo, Spain
  3. Institute for Systems Genetics, New York University Langone Health, United States
  4. Department of Mathematics and Volen Center for Complex Systems, Brandeis University, United States
12 figures, 2 tables and 1 additional file

Figures

Model of the nucleus and the cell as “a vesicle within a vesicle”, osmotically challenged.

(A) Schematic of the model and parameters used in the mathematical model: membrane tension σ, non-osmotic volume b, number (N) of macromolecules that cannot freely cross either the cell or nuclear …

Figure 2 with 2 supplements
The fission yeast nucleus behaves as an ideal osmometer.

(A) Images of cells expressing a plasma membrane marker mCherry-Psy1 (green) and a nuclear envelope marker Ish1-GFP (purple). Individual cells in isotonic medium (Ciso) were shifted to hypertonic or …

Figure 2—figure supplement 1
3D image analysis methods and use of an osmotic adaptation mutant allow for robust volume measurements.

Previous fission yeast cell studies estimated nuclear and cell volumes from length and single width measurements using assumptions of symmetric ellipsoid or cylindrical geometry (Facchetti et al., …

Figure 2—figure supplement 1—source data 1

N/C ratio comparison.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig2-figsupp1-data1-v2.xlsx
Figure 2—figure supplement 1—source data 2

WT - gpd1∆ background cells volumes over time after a hyper-osmotic shock.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig2-figsupp1-data2-v2.xlsx
Figure 2—figure supplement 1—source data 3

WT - gpd1∆ background cells and nuclei volumes over time after a hyper-osmotic shock.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig2-figsupp1-data3-v2.xlsx
Figure 2—figure supplement 2
Additional evidence that protoplasts behave as ideal osmometers.

(A) Defining an isotonic medium for protoplasts. The osmotic pressure of the medium changes the protoplasts’ volume and concentration of proteins due to addition or removal of water from the cell. …

Figure 3 with 1 supplement
The N/C ratio is maintained in osmotic shifts and upon cell-wall removal.

(A) The N/C ratio of the same cells before and after cell wall digestion (mean ± STD) reveals no statistical differences (paired t test, p=0.36). Right panel, overlay of the plasma membrane (green) …

Figure 3—source data 1

N/C ratio of the same cells before and after cell wall digestion.

Related to Figure 3A.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig3-data1-v2.xlsx
Figure 3—figure supplement 1
Measurements of cellular and nuclear volumes under osmotic shocks in protoplasts and whole cells.

(A) During protoplast preparation, a small portion of the cytoplasm was sometimes lost when the protoplast extruded out of the remaining cell wall. Image depicts a sum projection image of a …

Figure 4 with 1 supplement
Macromolecular crowding is affected similarly in the nucleus and cytoplasm under osmotic shocks.

(A) Images of protoplasts (left) and whole cells (right) expressing cytoplasmic 40 nm GEMs and nucleoplasmic 40 nm GEMs. Top, single time point image; bottom, maximum projection of 100 frames. …

Figure 4—source data 1

Effective diffusion of cytGEMs and nucGEMs.

Related to Figure 4B.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig4-data1-v2.xlsx
Figure 4—source data 2

Effective diffusion of cytGEMs in protoplasts in various sorbitol concentrations.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig4-data2-v2.xlsx
Figure 4—source data 3

Effective diffusion of cytGEMs plotted against cell volume under hypotonic and hypertonic.

Related to Figure 4D.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig4-data3-v2.xlsx
Figure 4—source data 4

Normalized effective diffusion of cytGEMs and nucGEMs in various sorbitol concentrations.

Related to Figure 4E.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig4-data4-v2.xlsx
Figure 4—figure supplement 1
Comparison of the cytoplasmic and nucleoplasmic GEMs diffusion and anomalous exponent under osmotic shocks.

(A) Example of MSD plots for cytoplasmic GEMs in whole cells under isotonic condition (0 M) or hypertonic shock (0.1–1.0 M of sorbitol). (B) Cytoplasmic (green) and nucleoplasmic (purple) GEM …

Figure 4—figure supplement 1—source data 1

cytGEMs MSD and anomalous diffusion exponent plots in whole cells.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig4-figsupp1-data1-v2.xlsx
Figure 4—figure supplement 1—source data 2

Effective diffusion of cytGEMs and nucGEMs in whole cells.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig4-figsupp1-data2-v2.xlsx
Figure 4—figure supplement 1—source data 3

cytGEMs MSD plots and anomalous diffusion exponent in protoplasts.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig4-figsupp1-data3-v2.xlsx
Figure 5 with 2 supplements
Inhibition of nuclear export rapidly leads to an increase in the N/C ratio and changes in crowding.

(A) Individual cells expressing plasma membrane and nuclear markers were imaged in time upon treatment with LMB or control (Ctrl). Images show a mid-focal plane of plasma membrane (green) and …

Figure 5—source data 1

Cell and nucleus volumes over time treated with LMB.

Related to Figure 5B–E.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-data1-v2.xlsx
Figure 5—source data 2

Ribosomal tagged subunit localization in cells treated with LMB.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-data2-v2.xlsx
Figure 5—source data 3

Effective diffusion of cytGEMs and nucGEMs in cells treated with LMB over time.

Related to Figure 5G.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-data3-v2.xlsx
Figure 5—source data 4

N/C ratio of total protein and RNA over time after the addition of LMB.

Related to Figure 5H.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-data4-v2.xlsx
Figure 5—source data 5

Normalized non-osmotic volume over time for cells and their nuclei in protoplasts treated with LMB.

Related to Figure 5I.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-data5-v2.xlsx
Figure 5—figure supplement 1
Effects of LMB on the N/C ratio and ribosomal protein localization.

(A) Bright field mid-focal plane (top) and max Z-projection (bottom) images of the plasma membrane (green) and nuclear membrane (purple) of whole cells treated with LMB over time. Cells were …

Figure 5—figure supplement 1—source data 1

Whole-cell volume and nuclear volume of distinct populations of cells treated with LMB.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-figsupp1-data1-v2.xlsx
Figure 5—figure supplement 1—source data 2

N/C ratio of total protein over time after the addition of LMB.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-figsupp1-data2-v2.xlsx
Figure 5—figure supplement 2
Effects of LMB and osmotic shifts on protoplasts.

(A–C) Time course of N/C ratio cellular volume and nuclear volume in individual control and LMB-treated protoplasts. (D) Z-sum projection image of the plasma membrane (green) and nuclear membrane …

Figure 5—figure supplement 2—source data 1

Time course of N/C ratio, cellular volume, and nuclear volume in individual LMB-treated protoplasts.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-figsupp2-data1-v2.xlsx
Figure 5—figure supplement 2—source data 2

BVH plots for protoplasts treated with LMB.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig5-figsupp2-data2-v2.xlsx
Figure 6 with 1 supplement
Inhibition of protein synthesis is accompanied by a similar decrease in nucleo-cytoplasmic crowding and does not perturb the N/C ratio.

(A) Overlay of the plasma membrane (green) and nuclear membrane (purple) of whole cells middle plane over time treated with 50 mg/ml cycloheximide (CHX, top) or not (Ctrl, bottom). (B) Single …

Figure 6—source data 1

Whole-cell volume and nuclear volume of distinct populations of cells treated with CHX.

Related to Figure 6B–E.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig6-data1-v2.xlsx
Figure 6—source data 2

Effective diffusion of cytGEMs and nucGEMs in cells treated with CHX over time.

Related to Figure 6F.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig6-data2-v2.xlsx
Figure 6—source data 3

N/C ratio of total protein and RNA over time after the addition of CHX.

Related to Figure 6G.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig6-data3-v2.xlsx
Figure 6—source data 4

Cytoplasmic and nucleoplasmic protein signals over time under CHX.

Related to Figure 6H.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig6-data4-v2.xlsx
Figure 6—figure supplement 1
CHX treatment produces no detectable change in N/C ratio.

(A) Bright field (top) and max Z-projection (bottom) overlay of the plasma membrane (green) and nuclear membrane (purple) of whole cells treated with 50 mg/ml CHX over time. Cells were selected to …

Figure 6—figure supplement 1—source data 1

Whole-cell volume and nuclear volume of distinct populations of cells treated with CHX.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig6-figsupp1-data1-v2.xlsx
Figure 7 with 1 supplement
Homeostatic correction of aberrant N/C ratios is explained by a passive nuclear growth model.

(A) Asynchronous WT and pom1Δ whole cells N/C ratio (mean ±STD) in growth medium, from 1 biological replicate. (B) Z-sum projection overlay of the plasma membrane (green) and nuclear membrane …

Figure 7—source data 1

WT and pom1Δ whole cells N/C ratio, cell, and nuclear volumes.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig7-data1-v2.xlsx
Figure 7—source data 2

Whole-cell volume, nuclear volume,N/C ratio and cellular growth rate of pom1Δ cells.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig7-data2-v2.xlsx
Figure 7—source data 3

Whole-cell volume, nuclear volume, N/C ratio and cellular growth rate of pom1Δ cells treated with CHX.

Related to Figure 7G–I.

https://cdn.elifesciences.org/articles/76075/elife-76075-fig7-data3-v2.xlsx
Figure 7—figure supplement 1
Quantitation of cellular and nuclear growth in pom1∆ mutant cells.

(A) Wildtype and pom1Δ whole-cell volumes used for Figure 7A. (B) Same as A for nuclear volumes of WT (purple) and pom1Δ (pink) cells. (C) Nuclear and (D) cell volume dynamics for pom1Δ cells. Gray …

Appendix 2—figure 1
Left panel: intact cells, right panel protoplasts.

(a) Nuclear solute number (mol), (b) cell solute number (mol), (c) nuclear concentration (M), (d) cell concentration (M). The model predicts the increase in nuclear solute number in LMB experiments …

Appendix 2—figure 2
Homeostatic behavior predicted by the model in the case of linear and exponential cell growth.

(a) Exponential growth yields a cell cycle-independent homeostasis, (b) Exponential growth leads to a faster recovery of the steady-state N/C ratio in the case of mutants that are unable to divide.

Appendix 3—figure 1
Limiting behaviors.

(a) Convergence to x1 in the small ϵC limit, (b) Full range of.ϵC (νbC=0.25).

Appendix 3—figure 2
Boyle Van’t Hoff plots for different values of the surface tension σC .

The curve in red corresponds to the critical tension σ*C ≈ 3.8 N/m, whereas the dotted line corresponds to σC = 0.

Appendix 3—figure 3
Limiting behavior upon varying the outer tension σC in the limit of large inner tension σN=σintactC .

Tables

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Genetic reagent (Schizosacchoromyces pombe)mCherry-Psy1, Ish1-GFPThis manuscriptFC3318h- ade6 <<mCherry-psy1 ish1-GFP:kanMX ura4-D18
Genetic reagent (S. pombe)gpd1 mutant, mCherry-Psy1, Ish1-GFPThis manuscriptFC3290h- ade6 <<mCherry-psy1 ish1-GFP:kanMX gpd1::hphMX6
ura4-D18 ade6-
Genetic reagent (S. pombe)gpd1 mutantThis manuscriptFC3291h- gpd1::hphMX6 ade6-M216 leu1-32 ura4-D18 his3-D1
Genetic reagent (S. pombe)mCherry-Psy1, Cut11-GFPThis manuscriptFC3319h? cut11-GFP:ura4 +ade6:mCherry-psy1
ura4-D18 leu1-32 ade6-M210
Genetic reagent (S. pombe)gpd1 mutant, CytGEMsThis manuscriptFC3320h- gpd1::hphMX6 pREp41X-Pfv-Sapphire leu1-32 ade6- leu1-32 ura4-D18 his7-366
Genetic reagent (S. pombe)gpd1 mutant, NucGEMsThis manuscriptFC3321h- gpd1::hphMX6 pREp41X-NLS-Pfv-Sapphire leu1-32 ade6- leu1-32 ura4-D18 his7-366
Genetic reagent (S. pombe)CytGEMsThis manuscriptFC3289h- pREp41X-Pfv-Sapphire ade6-M216 leu1-32 ura4-D18 his3-D1
Genetic reagent (S. pombe)NucGEMsThis manuscriptFC3322h- pREp41X-NLS-Pfv-Sapphire leu1-32 ade6- leu1-32 ura4-D18 his7-366
Genetic reagent (S. pombe)pom1 mutant, mCherry-Psy1, Ish1-GFPThis manuscriptFC3323h- pom1::ura4 ade6 <<mCherry-psy1 ish1-GFP:kanMX
Genetic reagent (S. pombe)Rpl3001-GFPChang Lab collectionFC3215h+rpl3001-GFP:kanR leu1-32 ura4-D18 ade6-210
Genetic reagent (S. pombe)Rpl2401-GFPChang Lab collectionFC3213h- rpl2401-GFP:kanR leu1-32 ura4-D18 ade6-216
Genetic reagent (S. pombe)Rps2-GFPChang Lab collectionFC3209h- rps2-GFP:kanR leu1-32 ura4-D18 ade6-210
Genetic reagent (S. pombe)1XE2C, GFP-Psy1This manuscriptFC3324h+act1p:1XE2C:HygR leu2:GFP-psy1 leu1- ura4-D18 his7-366
Chemical compound/drugYES 225 MediaSunrise Science Production#2011
Chemical compound/drugEdinburgh Minimum Media (EMM)MP Biomedicals#4110–32
Chemical compound/drugHistidineSigma-Aldrich#H8000
Chemical compound/drugUracilSigma-Aldrich#U0750
Chemical compound/drugAdenineSigma-Aldrich#A9126
Chemical compound/drugThiamineSigma-Aldrich#T4625
Chemical compound/drugLallzymeLallemand#EL011-2240-15
Chemical compound/drugLeptomycin B (LMB)Alfa Aesar#87081-35-4
Chemical compound/drugEthanolFisher BioReagents#BP2818-500
Chemical compound/drugDimethyl sulfoxide (DMSO)Fisher Scientific#67-68-5
Chemical compound/drugCycloheximide (CHX)Sigma-Aldrich#C7698
Chemical compound/drugAgaroseInvitrogen#16500500
Chemical compound/drug4% formaldehyde (methanol-free)Thermo Scientific#28,906
Chemical compound/drugRNAseThermo Scientific#EN0531
Chemical compound/drugFluorescein isothiocyanate isomer I (FITC)Sigma#F7250
Software, algorithmµManager v. 1.41Edelstein et al., 2010; Edelstein et al., 2014
Software, algorithmMatlabMathworksR2018b
Software, algorithmPythonDrake Jr and Van Rossum, 19955.5.0
Software, algorithmPrismGraphPadVersion 9.3.1
Software, algorithmFIJI ImageJSchindelin et al., 2012
Otherµ-Slide VI 0.4 channel slideIbidi#80,606microfluidic chambers
Otherµ-Slide VI 0.5 glass bottom channel slidesIbidi#80,607microfluidic chambers
Appendix 1—table 1
Parameter values and definitions.
SymbolDefinitionValueUnitsReferences
Parameters
NC,totSolute number in cell (including ions)2×10-14
8×10-14
molEstimated from Table 2-3 in Milo and Phillips, 2015
NCSolute number in cell (excluding ions)2×10-16
8×10-16
molEstimated from p. 106 in Milo and Phillips, 2015
NNSolute number in nucleus (excluding ions)2×10-17
6×10-17
molFit
σintactCCell wall surface tension10
–20
N/mMinc et al., 2009, Atilgan et al., 2015
σprotoCCell membrane surface tension4.5×10-4N/mLemière et al., 2021
σNNuclear membrane surface tension4.5×10-4N/mEstimate
νisoCCell non-osmotic volume fraction0.25Main Text Figure 2(D)
νisoNNucleus non-osmotic volume fraction0.25Main Text Figure 2(E)
Viso, intactCIntact cell isotonic volume88µm3Figure 3—figure supplement 1
Viso, intactNIntact nucleus isotonic volume6.7µm3Figure 3—figure supplement 1
Viso, protoCProtoplast isotonic volume81µm3Figure 3—figure supplement 1
Viso, protoNProtoplast nucleus isotonic volume6.6µm3Figure 3—figure supplement 1
ciso, intactIsotonic sorbitol concentration0M (mol/L)Figure 2—figure supplement 2
ciso, protoIsotonic sorbitol concentration0.4M (mol/L)Figure 2—figure supplement 2
Variables
VCCell volumeµm3
VNNuclear volumeµm3
coutExternal osmolarityM (mol/L)

Additional files

Download links